ラテン系人口の2型糖尿病とHNF1Aの低頻度変異の関連性
, Karol Estrada1, Ingvild Aukrust2
1Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts2Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston3Department of Medicine, Harvard Medical School, Boston, Massachusetts.
JAMA
|June 11, 2014
まとめ
HNF1A遺伝子の珍しい遺伝的変異は,ラテン系人口の2型糖尿病リスクの増加と関連しています. この発見は,この人口集団の将来のスクリーニングと治療戦略を参考にすることができます.
科学分野:
- 遺伝学 遺伝学とは
- エンドクリノロジー エンドクリノロジー
- 人口の健康 人口の健康
背景:
- ラテン系の人口は,世界的に2型糖尿病の高い罹患率を示しています.
- 遺伝的貢献を理解することは,標的を絞った介入に不可欠です.
研究 の 目的:
- 大規模なラテン系コホートにおける2型糖尿病に関連した珍しい遺伝子変異を調査する.
- これらの関連を支える分子メカニズムを探求する.
主な方法:
- 3756人のラテン系アメリカ人 (1794人が2型糖尿病患者) の全エクソームシーケンシング.
- 多民族のデータセットでの変異関連テスト (14,276人の参加者).
- タンパク質機能の実験的特徴付け.
主要な成果:
- 希少なHNF1Aミセンス変種 (p.E508K) は,2型糖尿病の罹患率 (OR=5.48) と強く関連している.
- この変種は,複製データセットにおけるラテン系個人に特異的であった.
- 実験的測定では,HNF-1Aタンパク質のトランザクティベーション活性が低下していることが示されました.
結論:
- 単一の低頻度のHNF1A変種は,ラテン系アメリカ人の2型糖尿病と関連しています.
- この変種はタンパク質の機能に影響を与え,病気のリスクに寄与する可能性があります.
- 発見は,この集団における標的型スクリーニングと治療の可能性を示唆しています.
関連する概念動画
Type II Diabetes I: Introduction
13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
Type I Diabetes II: Pathophysiology
68
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
68
Type II Diabetes II: Pathophysiology
23
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Diabetes Mellitus: Overview and Type I Subtype
5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K


